Total Payments
$5,287
2024 Payments
$514.09
Companies
32
Transactions
364
Medicare Patients
3,210
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$5,280 (99.9%)
Education$7.68 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,280 | 361 | 99.9% |
| Education | $7.68 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,180 | 83 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $926.94 | 80 | $0 (2024) |
| Daiichi Sankyo Inc. | $380.14 | 26 | $0 (2019) |
| PFIZER INC. | $339.00 | 22 | $0 (2024) |
| Sentynl Therapeutics, Inc. | $325.97 | 24 | $0 (2020) |
| Pernix Therapeutics Holdings, Inc. | $297.54 | 19 | $0 (2018) |
| BioDelivery Sciences International, Inc. | $221.56 | 15 | $0 (2021) |
| Egalet US Inc | $192.10 | 17 | $0 (2018) |
| Purdue Pharma L.P. | $188.18 | 11 | $0 (2018) |
| Vertical Pharmaceuticals, LLC | $178.78 | 15 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $514.09 | 27 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($256.32) |
| 2023 | $100.69 | 5 | PFIZER INC. ($64.79) |
| 2022 | $201.77 | 10 | Collegium Pharmaceutical, Inc. ($60.21) |
| 2021 | $590.51 | 38 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($296.77) |
| 2020 | $417.52 | 29 | Collegium Pharmaceutical, Inc. ($133.65) |
| 2019 | $628.93 | 53 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($249.77) |
| 2018 | $1,332 | 103 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($231.68) |
| 2017 | $1,502 | 99 | Collegium Pharmaceutical, Inc. ($192.29) |
All Payment Transactions
364 individual payment records from CMS Open Payments — Page 3 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/06/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Gastroenterology | ||||||
| 08/02/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.18 | General |
| Category: Opioid Analgesic | ||||||
| 07/21/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: PRIMARY CARE | ||||||
| 07/14/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.45 | General |
| Category: Opioid Analgesic | ||||||
| 06/21/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.08 | General |
| Category: Opioid Analgesic | ||||||
| 06/16/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: PRIMARY CARE | ||||||
| 06/07/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Gastroenterology | ||||||
| 06/07/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: Gastroenterology | ||||||
| 06/01/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Gastroenterology | ||||||
| 06/01/2021 | Almatica Pharma LLC | NAPRELAN (Drug), GRALISE | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: ANALGESIC | ||||||
| 05/25/2021 | RedHill Biopharma Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Opioid Antagonist | ||||||
| 05/24/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: Gastroenterology | ||||||
| 05/10/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $12.40 | General |
| Category: Opioid Analgesic | ||||||
| 04/26/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Chronic Pain | ||||||
| 04/22/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: PRIMARY CARE | ||||||
| 04/14/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Chronic Pain | ||||||
| 04/12/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Gastroenterology | ||||||
| 04/12/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Gastroenterology | ||||||
| 04/06/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.91 | General |
| Category: Opioid Analgesic | ||||||
| 03/31/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Chronic Pain | ||||||
| 03/17/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: PRIMARY CARE | ||||||
| 03/08/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Gastroenterology | ||||||
| 02/22/2021 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Chronic Pain | ||||||
| 02/16/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: PRIMARY CARE | ||||||
| 02/01/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,021 | 4,265 | $968,745 | $317,413 |
| 2022 | 16 | 815 | 3,615 | $832,753 | $278,827 |
| 2021 | 19 | 699 | 3,084 | $721,151 | $250,398 |
| 2020 | 18 | 675 | 2,800 | $671,856 | $198,195 |
Total Patients
3,210
Total Services
13,764
Medicare Billing
$1.0M
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 742 | $222,600 | $83,260 | 37.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 128 | 500 | $175,000 | $78,753 | 45.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 93 | 298 | $74,500 | $33,898 | 45.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 49 | 89 | $78,765 | $20,622 | 26.2% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 82 | 217 | $57,505 | $12,532 | 21.8% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 44 | 77 | $49,357 | $12,071 | 24.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 56 | 198 | $19,800 | $10,538 | 53.2% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 30 | 52 | $40,300 | $9,424 | 23.4% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 48 | 86 | $41,710 | $9,143 | 21.9% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 107 | 1,524 | $65,830 | $7,958 | 12.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 60 | 123 | $36,285 | $7,259 | 20.0% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 38 | 59 | $25,651 | $6,516 | 25.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 56 | 163 | $8,900 | $6,446 | 72.4% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 30 | 50 | $19,250 | $4,588 | 23.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $12,650 | $4,510 | 35.6% |
| 64479 | Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | Office | 2023 | 11 | 14 | $14,546 | $3,532 | 24.3% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 12 | 18 | $11,250 | $3,030 | 26.9% |
| 64480 | Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, each additional level | Office | 2023 | 11 | 14 | $8,456 | $1,792 | 21.2% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 12 | 18 | $6,390 | $1,543 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 136 | 949 | $284,700 | $108,266 | 38.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 108 | 313 | $109,550 | $49,029 | 44.8% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 51 | 116 | $102,660 | $28,338 | 27.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 67 | 160 | $40,000 | $17,836 | 44.6% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2022 | 80 | 220 | $58,300 | $13,029 | 22.3% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2022 | 47 | 104 | $50,440 | $11,634 | 23.1% |
About Dr. Jan Slomba, MD
Dr. Jan Slomba, MD is a Anesthesiology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689658007.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jan Slomba, MD has received a total of $5,287 in payments from pharmaceutical and medical device companies, with $514.09 received in 2024. These payments were reported across 364 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,280).
As a Medicare-enrolled provider, Slomba has provided services to 3,210 Medicare beneficiaries, totaling 13,764 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine
- Location Brooklyn, NY
- Active Since 11/30/2005
- Last Updated 06/13/2014
- Taxonomy Code 207L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689658007
Products in Payments
- RELISTOR (Drug) $1,238
- XTAMPZA (Drug) $627.16
- Morphabond ER (Drug) $299.56
- ZOHYDRO ER (Drug) $297.54
- Levorphanol (Drug) $276.23
- LYRICA (Drug) $227.81
- NURTEC ODT (Drug) $188.56
- Xtampza ER (Drug) $187.93
- LORZONE (Drug) $178.78
- BELBUCA (Drug) $176.66
- SPRIX (Drug) $131.63
- GENERAL - PAIN MANAGEMENT (Device) $107.24
- HYSINGLA ER (Drug) $102.58
- Movantik (Drug) $98.83
- RELISTOR ORAL (Drug) $95.81
- ADAPTIVESTIM (Device) $90.66
- NALOCET (Drug) $88.98
- Zipsor (Drug) $67.22
- Nucynta (Drug) $67.03
- ARYMO ER (Drug) $60.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Brooklyn
Dr. Mark Kronenfeld, M.d, M.D
Anesthesiology — Payments: $2.5M
Anesthesiology $2.5M
Mehrdad Hedayatnia, Md, MD
Anesthesiology — Payments: $27,710
Anesthesiology $27,710
Jason Kreiner, M.d, M.D
Anesthesiology — Payments: $19,382
Anesthesiology $19,382
Roman Shulkin, M.d, M.D
Anesthesiology — Payments: $15,731
Anesthesiology $15,731
Dr. Edwin Perez, M.d, M.D
Anesthesiology — Payments: $11,545
Anesthesiology $11,545
Shaesta Humayun, Md, MD
Anesthesiology — Payments: $7,219
Anesthesiology $7,219